Page1  2
Analysis for 233 Cases on Clinic Application of the Affiliated Overseas Chinese Hospital, Hospital of Jinan University
By Zhu Zhihui, Hu Wenjie and Yu Jian
Cardio-/cerebrovascular diseases are common and frequently-incurring diseases which seriously threatens the health of human being. With the growth of China’s national economy, the incidence rate of cardio-/cerebrovascular diseases is increasing year on year. In recent years, many therapeutic methods and drugs have emerged and we have obtained a better result. The Cardio-/cerebrovascular Therapeutic Instrument provided by King Tontown Medical Instrument Co., Ltd was first applied in the affiliated hospital of Sun Yat-sen Medical University and Zhujiang Hospital of the First Military Medical University and the therapeutic effect was satisfying. So our hospital introduced one set of this instrument in May 1996, and we have use it in clinics for more than one year with a better effect. Now, we report it as below:
I. Objects:
We got 233 patients including 128 male cases averaged at 67.5 years old.
1. Coronary heart disease: 100 cases of inpatients and they all had ECG check showing the change of myocardial ischemia. Some patients were with typical angina pectoris. Among them, 21 cases had a high blood pressure and 17 cases with abnormal heart rhythm.
2. High Blood Pressure: Ⅰ- Ⅱ: 80 cases with more than one year of illness course.
3. Autonomic Nerve Function Disorder: 10 cases with symptoms of palpitation, chest distress, short breath and bad sleep.
4. Vertebro-basilar Artery Insufficiency (including cervical spondylosis and hardening of common carotid artery): 8 cases
5. Myocarditis and Bacteria: 8 cases
6. Others: 7 cases with heart failure of RHD, chronic emphysema, pulmonary heart disease, diabetes and arthritis.

II. Therapeutic Method
To carry out the treatment by taking drugs and the CCTI of King Tontown Medical Instrument Co., Ltd. The frequency is 30-60 mins/time/day, and 10 times as one therapeutic course. The treatment will last for 1-3 courses.
III. Result and Experience
1. Effect Assessment: Analyzed on the objects we collected, the total effectiveness is 91.6%, including the effectiveness against coronary heart disease and autonomic nerve disorder reached 92.5. The patients get better in different extents. With CCTI, the patients were satisfied with its therapeutic effect. In addition that the patients with coronary heart disease turned butter, their ECG also improved. Some recovered completely. CCTI has an obvious effect against the autonomic nerve disorder. During the treatment, some of them were found re-attack of diseases that at the beginning they turned better, but later the symptom re-appeared. If treatment continued, the result would be satisfying after 1-2 course of treatment. For the high blood pressure patients, the blood pressure may slightly increase after treatment, and will reduce if continuing the treatment. It is not necessary to stop treatment. For the patients with vertebro-basilar artery insufficiency , head dizziness may be improved after treatment. 18.4% of patients failed with the following possible reasons: ① Wrong choice of patients: such as heart failure of RHD, chronic bronchitis, emphysema, myocarditis and arthritis. ② Long course of illness or discontinuing of the treatment. ③ The patients with high blood pressure need long-term treatment, but they stopped treatment when the blood pressure restored to normal.
2. Indications: According to our use of this instrument for more than one year, this instrument has a good effect against the coronary heart disease, angina pectoris, chronic coronary artery insufficiency, autonomic nerve disorder and vertebro-basilar artery insufficiency. The effect for short-term high blood pressure disease is comparatively satisfactory and is better for long-term treatment. We failed to evaluate the effect against the post-cerebrovascular disease sequela and high fat because there were no enough cases.
3. Course of Treatment: Different diseases need different courses of treatment. Generally speaking, ① coronary heart disease patients need to maintain treatment for one month at least. ② For patients with autonomic nerve disorder, they usually need 1-2 weeks for treatment, and among our patients, some only needed 3 days. ③ there were few of patients with arteriosclerosis and atheromatous plaque. One case with carotid artery plaque continued the treatment, and when re-checked 2 months after the treatment, the result showed that the plaque was shrinking and all symptoms disappeared.④ Because of the fewer cases, we need the further observation on the patients with cerebrovascular disease.
4. Social Benefits: CCTI provided a new therapeutic method for cardio-/cerebrovascular diseases, enabling the clinical doctors with one more choice for treatment of such diseases. Through the preparatory clinic application, better effects were obtained, and CCTI is well accepted by clinic doctors and patients and worth being promoted.
Economic Benefits: Accounted based the cost of CCTI, we charge RMB yuan per time, and if there are 6-10 cases/times as per day, we can get good economic benefits. And the use of this instrument also can decrease the taking of drugs to reduce the cost which meets the related regulations.
Page1  2
Home |  About Us |  Product |  News |  Clinic |  Contact